FDA product code QHA: X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device

QHA is the FDA product code for x-ray angiographic imaging based coronary vascular simulation software device. It is a Class II device, regulated under 21 CFR 892.1600 and reviewed by the Radiology panel. FDA has cleared 7 510(k) submissions under QHA, 5 in the last five years, from 5 different applicants. The average 510(k) review took 190 days (median 239); 204 days on average over the last three years.

Definition

X-ray angiographic imaging based coronary vascular simulation software device is a prescription device that provides an image analysis tool to assess blood flow in the coronary vascular system using X-ray angiographic imaging data. X-ray angiographic imaging based coronary vascular simulation software device solves algorithms and yields simulation-based metrics for certain cardiology applications. X-ray angiographic imaging based coronary vascular simulation software device cannot be used alone for clinical decision making and clinical management, and is a tool intended to generate results for use and review by a qualified clinician.

Classification

FieldValue
Device nameX-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device
Device classClass II
Regulation21 CFR 892.1600
Review panelRA — Radiology
Medical specialtyRadiology
Premarket route510(k)

510(k) clearances per year for QHA

YearClearancesAvg. review days
20191251
20211239
20232144
20241265
20252144

Compare with all 510(k) review times · Search every QHA clearance

Top QHA applicants

ApplicantClearancesLatest
ArteryFlow Technology Co., Ltd.32023-03-02
Spectrawave, Inc.12025-10-17
Qfr Solutions BV12025-04-04
Pie Medical Imaging BV12024-04-09
Medis Medical Imaging Systems BV12019-05-30

Most recent QHA clearances

510(k)ApplicantDeviceDecision dateReview days
K251355Spectrawave, Inc.X1-FFR2025-10-17170
K243769Qfr Solutions BVQFR (3.0)2025-04-04119
K232147Pie Medical Imaging BVCAAS Workstation2024-04-09265
K230303ArteryFlow Technology Co., Ltd.AccuFFRangio Plus2023-03-0227
K221711ArteryFlow Technology Co., Ltd.AccuICAS2023-02-28260

Recalls for QHA devices

FDA recall records list no recalls for product code QHA.

Frequently asked questions

What is FDA product code QHA?

QHA is the FDA product code for x-ray angiographic imaging based coronary vascular simulation software device. It is a Class II device, regulated under 21 CFR 892.1600 and reviewed by the Radiology panel.

What device class is QHA?

Class II, regulation 21 CFR 892.1600. Typical premarket route: 510(k).

How long does a 510(k) take for product code QHA?

Across 7 cleared submissions the average was 190 days from receipt to decision (median 239).

Which companies have the most QHA clearances?

ArteryFlow Technology Co., Ltd. (3); Spectrawave, Inc. (1); Qfr Solutions BV (1); Pie Medical Imaging BV (1); Medis Medical Imaging Systems BV (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Radiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times